Sign in to view content

Faricimab in Neovascular Age-Related Macular Degeneration: Year 2 Efficacy, Safety, and Durability Results From the Phase 3 TENAYA and LUCERNE Trials

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2022

Related

EVEREST II Study: Evaluation of Indocyanine Green Angiographic Features in Symptomatic Macular Polypoidal Choroidal Vasculopathy Over 24 Months
Colin S Tan, MBBS, MMed (Ophth), FRCSEd (Ophth)
Annual Meeting Talks
2019
Impact of PRAME Status on Gene Expression Profile to Predict Metastasis in Uveal Melanoma: Interim Analysis of the Collaborative Ocular Oncology Group Study Number 2 (COOG2)
Prithvi Mruthyunjaya, MD, MHS
Updates from the Field
2022
Phase 2 Trial of Ciliary Neurotrophic Factor for Macular Telangiectasia
Updates from the Field
2017

Category: wet AMD

See more